好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Diagnostic Accuracy of Radiomics Features from ^18F-FDG PET in Predicting Conversion from Mild Cognitive Impairment to Alzheimer’s Disease: A Systematic Review and Meta-analysis
Aging, Dementia, and Behavioral Neurology
P10 - Poster Session 10 (8:00 AM-9:00 AM)
13-004

To determine the pooled diagnostic accuracy of radiomics features derived from Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography(^18F-FDG PET (in predicting the conversion from mild cognitive impairment (MCI)to Alzheimer’s disease (AD)

Radiomics applied to ^18F-FDG PET provides a new way to detect subtle brain changes linked to AD, as it reflects regional cerebral glucose metabolism and can reveal characteristic metabolic patterns in patients suspected of having AD. Predicting which individuals with MCI will progress to AD is still challenging

We conducted a comprehensive search of PubMed, Embase, Scopus, and Web of Science up to July 2025. We included observational studies assessing radiomic features extracted from ^18F-FDG PET in adults with MCI to predict progression to AD. Methodological quality was assessed using the QUADAS-2 tool, and data were independently extracted by two reviewers. We used a bivariate random-effects model to pool sensitivity, specificity, positive and negative likelihood ratios, and diagnostic odds ratio. I², τ², and Q statistics were used to explore heterogeneity

Eight studies were identified, including a total of 2,735 patients with MCI. The pooled sensitivity and specificity of the radiomics-based model across five independent cohorts were 0.72 (95% CI: 0.50–0.88; I² = 49.9%) and 0.94 (95% CI: 0.77–0.98; I² = 85.3%), respectively. The pooled  area under the curve (AUC) and c-index were 0.798 (95% CI: 0.745–0.851; I² = 77.9%) and 0.775 (95% CI: 0.702–0.848; I² = 98.6%) across five and six cohorts, respectively. The sensitivity analysis revealed that most of heterogeneity related to a single outlier study; its exclusion reduced I² without affecting the robustness of the results


Radiomics features extracted from ^18F-FDG PET show promising diagnostic performance in predicting the conversion from MCI to AD. The pooled estimates indicate high specificity and acceptable sensitivity, suggesting that radiomics can complement conventional imaging assessment in identifying individuals at higher risk of progression

Authors/Disclosures
Khaled M. Mohamed, MD
PRESENTER
Dr. Mohamed has nothing to disclose.
Ahmed M. Moawed, medical student 5year Dr. Moawed has nothing to disclose.
Sara A. Elayan, MD Ms. Elayan has nothing to disclose.
Mayar N. Sinjilawi, Sr., MD Miss Sinjilawi has nothing to disclose.
Mohamed K. ElMasry, MBBS Dr. ElMasry has nothing to disclose.
Mohamed A. Salem, MBBCh Dr. Salem has nothing to disclose.
Abdallah M. Ibrahim Dr. Ibrahim has nothing to disclose.